DYN
Dyne Therapeutics, Inc. · Healthcare
Director Jason P Rhodes sold $11.3M of Dyne Therapeutics, Inc.
Sold$11,339,780
$22.64Price
500,789Shares
−35%Stake
What DYN did after the filing
- The stock from Mon, Feb 26 open, $22.75
- +19.7%
- S&P 500, same days
- +2.5%
Measured over 30 trading days, to the Apr 9 close.
Traded Wed, Feb 21. Filed Fri, Feb 23, 6:59 PM ET, after the close. Returns use the Feb 26 open and the Apr 9 close. Not investment advice.